PixarBio Corp. engages in the pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain. It researches and develops targeted delivery systems for drugs, devices, or biologics to treat pain, epilepsy, Parkinson's disease, and spinal cord injury. The company was founded by Frank M. Reynolds, Robert S. Langer, Randy Holmes-Farley and Katrin Holzhaus on August 4, 2014 and is headquartered in Fort Lee, NJ.